Here is a comprehensive, structured physiology notes covering all the topics you listed, drawn directly from Guyton & Hall, Costanzo Physiology, Medical Physiology, and Goodman & Gilman's.
PHYSIOLOGY MASTER NOTES
PART 1: MEMBRANE TRANSPORT MODES
A. Types of Transport (Overview)
| Type | Energy | Direction | Examples |
|---|
| Simple diffusion | None | Down gradient | O2, CO2, lipid-soluble drugs |
| Facilitated diffusion | None (carrier/channel) | Down gradient | Glucose (GLUT), water (AQP) |
| Primary active transport | ATP directly | Against gradient | Na-K ATPase, Ca-ATPase |
| Secondary active transport | Ion gradient (indirect) | Against gradient | SGLT (glucose-Na cotransport) |
B. Na⁺-K⁺ ATPase Pump (Primary Active Transport)
This is the most important active transporter in the body.
Structure: A membrane-bound pump with 2 subunits (alpha + beta). The alpha subunit has the catalytic + transport function.
Mechanism (electrogenic):
- 3 Na⁺ bind to intracellular sites on the pump
- ATP is hydrolyzed → pump becomes phosphorylated (conformational change)
- 3 Na⁺ are expelled to the extracellular space
- 2 K⁺ bind from extracellular side
- Dephosphorylation → pump returns to original conformation
- 2 K⁺ enter the cell
- Net result: 3 Na⁺ out, 2 K⁺ in per cycle - electrogenic (generates a net outward positive current)
Functions:
- Maintains resting membrane potential (cell interior negative)
- Prevents cell swelling (by controlling intracellular osmolality)
- Powers secondary active transport (provides Na gradient used by SGLT, NHE, etc.)
- Maintains excitability of nerve and muscle cells
Inhibited by: Ouabain, cardiac glycosides (digoxin) - these bind the extracellular K⁺ site
Source: Guyton and Hall Textbook of Medical Physiology, Comprehensive Clinical Nephrology 7e
C. Facilitated Diffusion
- Movement down the electrochemical gradient using a carrier protein or channel - no energy required
- Shows saturation kinetics (Vmax) and specificity
- Examples:
- GLUT-1 to GLUT-5 - glucose entry into cells (GLUT-4 is insulin-dependent in muscle/fat)
- Aquaporins (AQP) - water channels
- Ion channels (Na⁺, K⁺, Ca²⁺, Cl⁻ channels)
Differences from simple diffusion:
- Carrier-mediated (shows saturation, competitive inhibition)
- Faster rates at low concentrations
- Can be regulated (e.g., GLUT-4 insertion stimulated by insulin)
D. Edema - Pathophysiology
Edema = excess fluid in interstitial compartment. Governed by Starling forces:
Net filtration = Kf [ (Pc - Pi) - σ(πc - πi) ]
Where: Pc = capillary hydrostatic pressure, Pi = interstitial hydrostatic pressure, πc = capillary oncotic pressure, πi = interstitial oncotic pressure
Causes of edema:
| Mechanism | Cause | Example |
|---|
| ↑ capillary hydrostatic pressure | Venous obstruction, heart failure | Pitting edema in CCF |
| ↓ plasma oncotic pressure | Hypoalbuminemia | Nephrotic syndrome, liver failure, kwashiorkor |
| ↑ capillary permeability | Inflammation, burns, anaphylaxis | Angioedema |
| Lymphatic obstruction | Filariasis, post-mastectomy | Lymphedema (non-pitting) |
| Na⁺ retention | ↑ aldosterone | Renal edema |
Key rule: Pitting edema = high protein content (exudate in inflammation) or low protein (transudate in CCF, nephrotic). Lymphedema = non-pitting, protein-rich.
PART 2: HOMEOSTASIS
Homeostasis = the tendency of the body to maintain a stable internal environment despite external changes.
Components of a homeostatic control system:
- Receptor/sensor - detects deviation from set point
- Control center (integrating center) - processes and compares to set point
- Effector - corrects the deviation
Types of feedback:
- Negative feedback - most common; opposes the change (e.g., thermoregulation, blood pressure, blood glucose)
- Positive feedback - amplifies the change (e.g., childbirth oxytocin surge, LH surge at ovulation, blood clotting cascade)
Important set points:
- Core body temp: 37°C
- Blood pH: 7.35-7.45
- Plasma osmolality: 280-295 mOsm/kg
- Blood glucose: 70-100 mg/dL (fasting)
PART 3: NERVE & MUSCLE PHYSIOLOGY
A. Action Potential
The action potential is a rapid reversal of membrane polarity that propagates along a nerve or muscle fiber.
Resting membrane potential: -70 mV (nerve), -90 mV (skeletal muscle), -85 mV (cardiac muscle)
- Maintained by: K⁺ leakage outward, Na-K ATPase pump
Phases of action potential (nerve):
| Phase | Ion involved | Gate status |
|---|
| Resting | K⁺ dominant | Na⁺ channels closed |
| Depolarization (rising) | Na⁺ rapid influx | Na⁺ activation gates OPEN |
| Overshoot | +30 mV | Peak depolarization |
| Repolarization (falling) | K⁺ efflux + Na⁺ inactivation | Na⁺ inactivation gates close; K⁺ channels open |
| After-hyperpolarization | Excess K⁺ efflux | K⁺ channels slow to close |
| Return to resting | Na-K pump | Gradual restoration |
Threshold: ~-55 mV. If this is not reached, no action potential fires.
B. All-or-None Law
"Once threshold is reached, the action potential fires with maximum amplitude regardless of the strength of the stimulus. Subthreshold stimuli produce no response."
- The size and duration of an action potential are constant for a given neuron
- Stimulus strength is coded not by AP amplitude but by frequency of firing
- The law applies to: nerve fibers, skeletal muscle fibers, cardiac muscle
C. Refractory Period
Absolute Refractory Period (ARP):
- No stimulus, however strong, can produce another AP
- Na⁺ activation gates are open OR Na⁺ inactivation gates are closed (h gates shut)
- Duration: ~1-2 ms in nerve; 200-300 ms in cardiac muscle (protective - prevents tetanus)
Relative Refractory Period (RRP):
- Follows ARP; a stronger-than-normal stimulus CAN fire another AP
- K⁺ channels still open; membrane hyperpolarized
- Corresponds to repolarization/after-hyperpolarization phase
Clinical significance of cardiac ARP: The long ARP in cardiac muscle prevents summation and tetanus, ensuring effective pumping function.
D. Saltatory Conduction
In myelinated fibers, the myelin sheath (deposited by Schwann cells, lipid substance = sphingomyelin) acts as an insulator, reducing ion flow through covered membrane by ~5000-fold.
Nodes of Ranvier = small uninsulated gaps (2-3 µm) between adjacent Schwann cells, occurring every 1-3 mm.
Saltatory conduction mechanism:
- Action potential can only occur at the nodes (where ion channels are concentrated)
- Current flows from one depolarized node to the next resting node through extracellular fluid
- The AP "jumps" from node to node (saltus = jump)
Advantages of saltatory conduction:
- Speed - conduction velocity up to 100-120 m/s (vs. 0.5-2 m/s in unmyelinated fibers)
- Energy efficiency - ion exchange only at nodes, less Na-K pump activity needed
- Protection - if one node is blocked, current can jump 2-3 nodes
Source: Guyton and Hall Textbook of Medical Physiology
E. Wallerian Degeneration
After a peripheral nerve is cut or severely injured (grade II-V), the axon segment distal to the injury degenerates - this is Wallerian degeneration.
Timeline of events:
Distal segment (main events):
- Hours: Disruption of axonal plasma membrane → rapid influx of Ca²⁺ and Na⁺
- This activates proteolytic enzymes (calpains) - cascade resembling apoptosis
- Day 3: Schwann cells retract from nodes of Ranvier
- Days 3-7: Schwann cells and macrophages digest myelin (phagocytosis)
- The entire axonal process takes ~1 week
- Schwann cells proliferate and form Bands of Büngner (guides for regeneration)
Proximal segment (cell body changes = Chromatolysis):
- Nucleus moves eccentrically
- Nissl substance (rough ER) dissolves/disperses
- Cell body swells
- Upregulation of transcription factors: switches from maintenance mode to protein synthesis mode
- Key protein upregulated: c-Jun (in Schwann cells)
Nerve regeneration:
- Axon sprouts grow from proximal stump at ~1-4 mm/day
- Collateral sprouting from intact axons reinnervates denervated muscle
- Remyelination occurs with thinner myelin and shorter internodes
Applied: Nerve conduction studies show loss of compound action potential distal to lesion. EMG shows denervation fibrillations at 2-3 weeks.
Source: Bradley and Daroff's Neurology in Clinical Practice
F. Strength-Duration Curve
This curve relates the minimum stimulus intensity (strength) needed to fire an AP to the duration for which that stimulus is applied.
Key concepts:
- Rheobase: The minimum stimulus strength (intensity/current) that can trigger an AP when applied for an infinite (very long) duration
- Chronaxie: The minimum duration of a stimulus needed to fire an AP when applied at twice the rheobase intensity
- Chronaxie is a measure of tissue excitability
- Short chronaxie = more excitable (e.g., motor nerve: ~0.05 ms)
- Long chronaxie = less excitable (e.g., cardiac muscle: ~2 ms)
Relationship: Strength × Duration = constant (hyperbolic curve)
Clinical use:
- Distinguish nerve vs. muscle excitability (denervated muscle has longer chronaxie)
- Assess nerve injuries (Wallerian degeneration raises chronaxie)
- Design electrical stimulation parameters in physiotherapy
PART 4: NEUROMUSCULAR JUNCTION (NMJ) TRANSMISSION ⭐ IMPORTANT
Anatomy of the Motor End Plate
- Presynaptic terminal: axon terminal filled with ~300,000 ACh vesicles + mitochondria
- Synaptic cleft: 20-30 nm wide, contains acetylcholinesterase (AChE)
- Postsynaptic membrane: muscle membrane with deep subneural clefts (increase surface area) and nicotinic ACh receptors (nAChR) concentrated at the mouths of clefts
Step-by-Step Transmission
Step 1 - Action potential arrives at nerve terminal
- AP travels down the motor neuron to the presynaptic terminal
Step 2 - Ca²⁺ entry into presynaptic terminal
- Depolarization opens voltage-gated P-type (and L-type) Ca²⁺ channels at active zones
- Ca²⁺ flows from extracellular fluid into the nerve terminal
- No Ca²⁺ = no ACh release (critical concept)
- Doubling [Ca²⁺] increases quantal ACh release 16-fold
Step 3 - ACh vesicle mobilization and fusion
- Ca²⁺ activates Ca²⁺-calmodulin-dependent protein kinase
- This phosphorylates synapsin proteins that anchor vesicles to the cytoskeleton
- Vesicles are freed → move to active zones → dock → fuse with membrane (exocytosis)
- ~125 vesicles released per AP (each vesicle = 1 quantum = ~10,000 ACh molecules)
Step 4 - ACh diffuses across cleft and binds nAChRs
- Nicotinic ACh receptors are ligand-gated ion channels (pentameric: 2α, 1β, 1γ, 1δ)
- ACh binds 2 alpha subunits → channel opens
- Na⁺ flows in >> K⁺ flows out → End-plate potential (EPP) generated
Step 5 - End-plate potential triggers muscle AP
- EPP is large enough (always suprathreshold) to depolarize adjacent voltage-gated Na⁺ channels
- Full muscle AP fires (All-or-None)
Step 6 - ACh termination by AChE
- Acetylcholinesterase in the cleft hydrolyzes ACh → acetate + choline
- Choline is taken back up by presynaptic terminal (reused for ACh synthesis)
- This terminates the signal within milliseconds
Applied: Myasthenia Gravis (MG) ⭐
Definition: Acquired autoimmune disorder of the NMJ postsynaptic membrane.
Pathophysiology:
- Autoantibodies (IgG) directed against nicotinic ACh receptors (nAChR) on the postsynaptic muscle membrane
- Antibodies against the Main Immunogenic Region (MIR) of the α subunit
- Mechanism of receptor loss: complement activation + accelerated internalization and destruction of receptors
- Result: Reduced surface density of nAChR → reduced EPP amplitude → failure of NMJ transmission
Key electrophysiology: Miniature end-plate potential (MEPP) amplitude is reduced (fewer receptors), but frequency is normal (quantal release from nerve is intact)
Clinical features:
- Fatigable muscle weakness - worse with repeated use, better after rest
- Ptosis, diplopia (extraocular muscles most commonly affected first)
- Dysphagia, dysarthria, dyspnea
- Bimodal age: women in 20s (thymic hyperplasia) | men in 60s (thymoma)
- Crisis = respiratory muscle weakness → respiratory failure
Two forms:
- Ocular MG - only extraocular muscles
- Generalized MG - all skeletal muscles
Diagnosis:
- Anti-AChR antibodies (positive in ~85%)
- Anti-MuSK antibodies (seronegative MG)
- Tensilon (edrophonium) test - short-acting AChE inhibitor → transient improvement
- Repetitive nerve stimulation: decremental response (amplitude decreases with repeated stimulation)
- Single-fiber EMG: increased jitter
Treatment:
| Approach | Drugs/Methods |
|---|
| Enhance ACh | Pyridostigmine (AChE inhibitor) - must titrate carefully |
| Immunosuppression | Corticosteroids, azathioprine, mycophenolate |
| Remove antibodies | Plasmapheresis, IVIG |
| Surgery | Thymectomy (especially if thymoma; 75% improvement) |
Cholinergic crisis vs. Myasthenic crisis: Overdose of AChE inhibitor → excess ACh → persistent depolarization → Na⁺ channels inactivated → paradoxical weakness. Differentiated by edrophonium test (improves myasthenic; worsens cholinergic).
Lambert-Eaton Myasthenic Syndrome (LEMS) - contrast:
- Antibodies against presynaptic voltage-gated Ca²⁺ channels (not AChR)
- Less ACh released
- Weakness improves with repeated use (more Ca²⁺ accumulates)
- Associated with small cell lung cancer
- Incremental response on repetitive nerve stimulation
Sources: Medical Physiology (Boron & Boulpaep); Goodman & Gilman's Pharmacological Basis; Miller's Anesthesia
PART 5: EXCITATION-CONTRACTION COUPLING (ECC) ⭐ IMPORTANT
Molecular Basis of Muscle Contraction (Sliding Filament Theory)
Sarcomere components:
- Thick filament: Myosin (tail + globular head with actin-binding site + ATPase activity)
- Thin filament: Actin + Tropomyosin + Troponin complex
- Troponin C (TnC) - binds Ca²⁺
- Troponin I (TnI) - inhibitory subunit
- Troponin T (TnT) - binds tropomyosin
- At rest: tropomyosin blocks the myosin-binding sites on actin
The Transverse Tubule (T-Tubule) - Sarcoplasmic Reticulum (SR) System
- T-tubules = invaginations of sarcolemma running transversely → carry AP to cell interior
- In skeletal muscle: T-tubule at A-I junction (2 per sarcomere)
- SR surrounds myofibrils; terminal cisternae abut T-tubules
- Triad = 1 T-tubule flanked by 2 terminal cisternae of SR
Steps of ECC in Skeletal Muscle
Step 1: Muscle AP spreads along sarcolemma → travels into T-tubules
Step 2: Depolarization of T-tubule detected by Dihydropyridine Receptors (DHPR) = voltage sensors (L-type Ca²⁺ channels) on T-tubule membrane
Step 3: DHPR undergoes conformational change → mechanically linked to Ryanodine Receptors (RyR1) on SR terminal cisternae
Step 4: RyR1 channels open → massive Ca²⁺ release from SR into cytosol
- Ca²⁺ concentration rises from <10⁻⁷ M (resting) to 2×10⁻⁴ M (500-fold increase)
- This is 10× the level needed for maximum contraction
Step 5 - Cross-bridge cycle:
- Ca²⁺ binds Troponin C
- Conformational change in troponin complex → tropomyosin shifts → exposes myosin-binding sites on actin
- Myosin head (with ADP + Pi) attaches to actin → forms cross-bridge
- Power stroke - myosin head pivots → thin filament pulled toward M line (ADP + Pi released)
- New ATP binds → cross-bridge detaches
- ATP hydrolysis re-cocks the myosin head (high-energy configuration)
- Cycle repeats as long as Ca²⁺ is present
In rigor mortis (after death): no ATP → myosin remains attached to actin permanently
Step 6 - Relaxation:
- After AP ends, SERCA (Sarcoplasmic Reticulum Ca²⁺-ATPase) pump actively pumps Ca²⁺ back into SR
- SR concentrates Ca²⁺ ~10,000-fold using ATP
- Calsequestrin inside SR binds up to 40 Ca²⁺ per molecule (storage protein)
- Ca²⁺ concentration in cytosol falls back below threshold → tropomyosin re-blocks actin sites → relaxation
Key Difference: Skeletal vs. Cardiac ECC
| Feature | Skeletal Muscle | Cardiac Muscle |
|---|
| Ca²⁺ source | SR only (DHPR is voltage sensor, mechanically linked to RyR1) | SR + extracellular (CICR - Ca²⁺-induced Ca²⁺ release via L-type channels) |
| T-tubule location | A-I junction | Z line |
| Ca²⁺ requirement | Independent of extracellular Ca²⁺ | Depends on extracellular Ca²⁺ entry (trigger Ca²⁺) |
| DHPR-RyR coupling | Mechanical (direct) | Calcium-mediated (indirect CICR via RyR2) |
Sources: Guyton and Hall Textbook of Medical Physiology; Costanzo Physiology 7e; Miller's Anesthesia
QUICK PHARMACOLOGY LINKS
| Agent | Mechanism at NMJ |
|---|
| Succinylcholine | Depolarizing NMJ blocker (binds nAChR, persistent depolarization) |
| Rocuronium/vecuronium | Non-depolarizing NMJ blocker (competitive antagonist at nAChR) |
| Neostigmine/Pyridostigmine | AChE inhibitor → ↑ ACh (reverses NDMR block, treats MG) |
| Botulinum toxin | Cleaves SNARE proteins → blocks ACh vesicle exocytosis |
| 4-Aminopyridine | K⁺ channel blocker → prolongs AP → more Ca²⁺ entry → more ACh release |
| Ouabain/Digoxin | Inhibits Na-K ATPase |
Primary sources: Guyton and Hall Textbook of Medical Physiology; Costanzo Physiology 7e; Medical Physiology (Boron & Boulpaep); Goodman & Gilman's Pharmacological Basis of Therapeutics; Miller's Anesthesia 10e; Bradley and Daroff's Neurology in Clinical Practice